• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    M

    Maudsley 医院

    Maudsley Hospital,South London and Maudsley NHS Foundation Trust
    EST. 1923
    1,697论文总数
    5.8万引用总数

    The Maudsley Hospital is a British psychiatric hospital in south London. The Maudsley is the largest mental health training institution in the UK. It is part of South London and Maudsley NHS Foundation Trust, and works in partnership with the Institute of Psychiatry, King's College London. The hospital was one of the originating institutions in producing the Maudsley Prescribing Guidelines. It is part of the King's Health Partners academic health science centre and the National Institute for Health Research (NIHR) Biomedical Research Centre for Mental Health.

    论文量&引用量时间轴

    机构学者

    论文(1697)

    年份
    起
    –
    止
    排序
    1The Positioning of Women Nurses As ‘risky’ in United Kingdom Suicide Prevention Policy Documents: a Critical Policy Analysis
    Hilary Causer,Anna Conolly, Barbara Howard-Hunt, Chinenye Anetekhai, Carrie-Ann Black, Elaine Scott,Ruth Riley

    IntroductionWomen nurses in the global north more likely to die by suicide than women in other occupations. Current suicide research is largely quantitative and individualises and pathologises nurses. Suicide prevention policy echoes this approach, focusing on individualised risk factors, thereby missing the opportunity to explore contextual, systemic and workplace factors that may contribute to suicide in women nurses. This critical policy analysis explores how distress, suicidality and suicide prevention in women nurses is positioned and constructed in policy and with what political, social and personal consequences.MethodsA critical intersectional feminist design was adopted to interrogate the data and draw out issues pertinent to women nurses. This work was co-produced with women nurses. Bacchi’s ‘What’s the problem represented to be?’ method of critical policy analysis to inform the data extraction and analysis. We employed a feminist perspective and adapted Lazar’s five principles of feminist discourse praxis. Documents were sourced from governmental and organisational websites and via search engines and were screened against our inclusion criteria. Data was extracted to inform an overview of included documents and for the critical analysis.ResultsNine documents met our inclusion criteria. We found some stark silences in the included documents regarding suicide in women nurses, and in the health services. Suicide is positioned as a problem of risky people, and as a workforce, rather than a workplace issue. Three narratives were developed to convey the core findings of the analysis: Invisible nurses and silenced suicide; People as risky; Responsibilising the workforce. Four themes sit within ‘Responsibilising the workforce’: Nurses as risky; Knowledge and means; Workforce problems; Workforce solutions.ConclusionCurrent policy documents engage a language of risk which pathologises and responsibilises individuals and minoritised groups as causing high rates of suicide within communities and health workplaces. The impact of socio-economic, political and systemic contexts is overlooked as shaping the lives of suicidal people.

    2026Frontiers in sociology(2026)引用:1
    引用
    AI阅读
    加入学术空间
    2Management of Clozapine-Resistant Schizophrenia.
    John Lally,Siobhan Gee,Caroline Hynes-Ryan,Korinne Northwood,Dolores Keating,Shuichi Suetani,Dan Siskind,Brian O'Donoghue

    The ANZJP 2026 schizophrenia guideline appropriately emphasises the importance of identifying treatment-resistant schizophrenia and the timely initiation of clozapine. However, despite clear guidance on when to commence clozapine, there remains comparatively limited direction regarding the systematic assessment and management of individuals who show an inadequate response to clozapine, commonly termed clozapine-resistant schizophrenia. The absence of consistent, operationalised guidance contributes to variability in clinical practice and uncertainty regarding optimal management strategies. In this perspective article, we summarise practical, evidence-informed recommendations to assist clinicians in the assessment and management of clozapine-resistant schizophrenia. Current evidence supports the early use of clozapine once treatment-resistant schizophrenia is established, with delayed clozapine use associated with poorer outcomes. In individuals with persistent symptoms despite clozapine treatment, systematic assessment is required to exclude pseudoresistance, including non-adherence, drug interactions, altered metabolism, and subtherapeutic plasma clozapine concentrations. Therapeutic drug monitoring is therefore a core component of care. Optimisation of clozapine should prioritise individualised adjustment of plasma concentrations guided by clinical response, adverse effects, and tolerability, rather than reliance on fixed concentration thresholds alone. Where an adequate trial of optimised clozapine has failed, augmentation strategies may be considered, with preference given to interventions supported by meta-analytic findings and real-world effectiveness data, while recognising the modest and inconsistent benefits observed across studies. Augmentation trials should be time-limited, systematically evaluated and if no meaningful improvement occurs, should be discontinued rather than continued indefinitely. Despite decades of research, no augmentation strategy has demonstrated consistent efficacy in clozapine-resistant schizophrenia. Future research should prioritise adequately powered, placebo-controlled trials and standardised definitions of treatment-resistant schizophrenia and clozapine-resistant schizophrenia to enable clearer treatment algorithms and more reliable clinical pathways for this patient group.

    2026The Australian and New Zealand journal of psychiatry(2026)
    引用
    AI阅读
    加入学术空间
    3#8985 the ‘MRI Meeting’: is It an Effective, Safe and Acceptable Contribution to Patient Care?
    Rebecca Howard, Daisy Tulloch, Daniel Davies, Alastair Santhouse, Simon Harrison
    2026The BNPA 39th Annual Conference(2026)
    引用
    AI阅读
    加入学术空间
    4RELAX Perinatal Digital Intervention to Prevent Increasing Anxiety
    Colette R. Hirsch,Brittannia Volkmer,Yogini Sawjani, Nathalie Towner,Mary Newburn, Jo Bennett,Laura Bridle, Megan McGovern, Louise MacGregor,Laura McCabe,Katherine Clark, Sophie Webster,

    Importance Anxiety disorders affect 1 in 5 pregnant women and birthing people. Cognitive bias modification for interpretation reduces anxiety and repetitive negative thinking (RNT; a risk factor for anxiety) among nonpregnant samples. Objective To evaluate whether adding pregnancy-tailored cognitive bias modification for interpretation to usual maternity care (UC) prevents increased anxiety during pregnancy; reduces anxiety, depression, and RNT before and after birth; and improves functioning before and after birth compared with UC. Design, Setting, and Participants The RELAX (Reducing Levels of Anxiety) 2-arm, parallel-group, multisite, superiority, phase 2b randomized clinical trial recruited participants from June 2023 to July 2024, with final assessment in April 2025. Participants included pregnant individuals in the UK at 16 to 28 weeks’ gestation, with high RNT and up to moderate anxiety, recruited via antenatal clinics or self-referral. Intervention Participants were randomized to the self-led digital intervention (RELAX plus UC), involving twelve 17-minute sessions over 4 weeks, or to UC. Main Outcomes and Measures Assessments took place at baseline before randomization (T0) and 4 weeks (T1), 8 weeks (T2), and 36 weeks (T3; 12-24 weeks after birth) after randomization. The primary outcome was anxiety, as assessed by the 7-item Generalized Anxiety Disorder scale (GAD-7) at T2 and as a secondary outcome at T3. Secondary outcomes included RNT (assessed by the 10-item trait version of the Repetitive Thinking Questionnaire [RTQ-10]), depression (general and perinatal, assessed by the Patient Health Questionnaire–9 [PHQ-9] and Edinburgh Postnatal Depression Scale [EPDS]), perinatal anxiety (assessed by the Perinatal Anxiety Screening Scale [PASS]), worry (assessed by the Penn State Worry Questionnaire [PSWQ]), and functioning (assessed by the Work and Social Adjustment Scale [WSAS]). Interpretation bias at T1 was the hypothesized mechanism. Analysis was performed using a modified intention-to-treat approach. Results A total of 268 participants were randomized (mean [SD] age 33.7 [3.9] years; 174 [64.9%] married). Anxiety was significantly lower for RELAX participants vs UC (mean GAD-7 difference, –1.5; 95% CI, −2.4 to −0.6; P = .001). Depression (mean PHQ-9 difference, –0.8; 95% CI –1.5 to –0.1; and mean EPDS difference, –1.1; 95% CI, –2.0 to –0.2), RNT (mean RTQ-10 difference, –2.7; 95% CI, –4.5 to –0.9), worry (mean PSWQ difference, –3.6; 95% CI, –5.9 to –1.3), and perinatal anxiety (mean PASS difference, –5.5; 95% CI, –8.2 to –2.8) were significantly lower at T2. Effects on general anxiety (mean GAD-7 difference, –1.0; 95% CI, –1.9 to –0.1), postnatal depression (mean EPDS difference, –1.3; 95% CI, –2.4 to –0.2), and RNT (mean RTQ-10 difference, –2.4; 95% CI, –4.6 to –0.2) were sustained at T3. RELAX promoted more positive interpretations vs UC (mean difference, 2.1; 95% CI, 1.8-2.3) that did not mediate effects at T2 (indirect effect on GAD-7, –0.2; percentile bootstrap 95% CI, –0.4 to 0.1). Functioning did not differ at T2 (mean WSAS difference, –1.0; 95% CI, –2.5 to 0.5) or T3 (mean WSAS difference, –0.8; 95% CI, –2.7 to 1.2), nor did perinatal anxiety (mean PASS difference, –2.1; 95% CI, –5.5 to 1.4), general depression (mean PHQ-9 difference, –0.2; 95% CI, –1.2 to 0.9), or worry (mean PSWQ difference, –1.4; 95% CI, –4.1 to 1.3) at T3. Conclusions and Relevance In this randomized clinical trial, anxiety was lower during pregnancy and postnatally for RELAX plus UC participants compared with those receiving UC. Integrating RELAX into maternity care for those at risk of increased anxiety has potential to improve maternal mental health. Trial Registration https://www.isrctn.com/ISRCTN12754931

    2026JAMA Network Open(2026)
    引用
    AI阅读
    加入学术空间
    5Gastrointestinal Symptoms in Adults with Elevated Autistic Traits: the Mediating Role of General and Gastrointestinal-Specific Anxiety
    Amy Tong, Martina Carboni, James L. Findon

    Background: Gastrointestinal symptoms (GIS) are prevalent in autistic adults, but little is known about their psychological predictors. This study examined general (anxiety, gastrointestinalspecific anxiety [GSA], neuroticism) and autism-specific (sensory over-responsivity [SOR], autism severity) psychological predictors of GIS in adults with varying levels of autistic traits. Methods: One hundred and fifty-five adults without a formal autism diagnosis were divided into high (AQ+, n = 72) and low (AQ-, n = 83) autistic trait groups based on a cut-off score of 32 on the Autism Quotient. Participants completed self-report measures of gastrointestinal symptoms, autistic traits, and psychological characteristics including anxiety, GSA, neuroticism and SOR. Group differences were assessed using analysis of variance, and hierarchical regression was used to identify independent predictors of GIS. Anxiety and GSA emerged as the only independent predictors and were entered as parallel mediators testing whether they explained the association between autistic traits and GIS. Results: The AQ+ group reported significantly greater GIS severity and frequency, particularly diarrhoea, constipation, and abdominal pain, together with higher anxiety, GSA, neuroticism, and SOR. In regression analyses, only anxiety and GSA independently predicted GIS. Mediation analysis indicated full mediation, with indirect effects via GSA (b = 0.0190, 95 % CI [0.0118, 0.0280]) and anxiety (b = 0.0089, 95 % CI [0.0040, 0.0148]). The model explained 50.4 % of variance in GIS severity. Conclusions: Anxiety, particularly GSA, plays a central role in explaining GIS severity in adults with elevated autistic traits. Interventions targeting these psychological factors may offer a promising route to reducing GIS in this population.

    2026RESEARCH IN AUTISM(2026)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 1697 篇论文

    合作机构(100)

    伦敦国王学院合作论文 54
    国王大学合作论文 47
    牛津大学合作论文 20
    伦敦大学合作论文 17
    伦敦大学学院合作论文 17
    盖伊医院合作论文 15
    剑桥大学合作论文 14
    国王学院医院合作论文 12
    South London and Maudsley NHS Foundation Trust合作论文 11
    诺丁汉大学合作论文 10

    机构统计